{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-112629","form_type":"8-K","ticker":"CARM","cik":"0001485003","company_name":"Carisma Therapeutics Inc.","filed_at":"2024-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.562913+00:00","generated_at":"2026-05-30T08:12:47.549507+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Carisma Therapeutics announces director resignation and appointment of Sohanya Cheng","bullets":["Michael Torok resigns from board effective Oct 31, 2024; cites other professional commitments, no disagreement.","Sohanya Cheng elected director effective Oct 31, 2024 as Class I director until 2027 annual meeting.","Cheng will serve on audit committee (Chair: Marella Thorell, Sanford Zweifach, Cheng).","Compensation: $40K annual cash retainer, plus committee fees, and option for 38,700 shares at Oct 31 closing price, vesting monthly over 3 years."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-112629","json":"https://secwatch.observer/filing/0001104659-24-112629.json","markdown":"https://secwatch.observer/filing/0001104659-24-112629.md","text":"https://secwatch.observer/filing/0001104659-24-112629.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1485003/000110465924112629/0001104659-24-112629-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1485003/000110465924112629/tm2426977d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T08:12:47.549507+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"04615deb54","claim":"Sohanya Cheng was elected as Director at Carisma Therapeutics Inc..","evidence_excerpt":"On October 30, 2024, the Board elected Sohanya Cheng as a director of the Company, effective October 31, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1485003/000110465924112629/0001104659-24-112629-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"1bb7587302","claim":"Michael Torok resigned as Director at Carisma Therapeutics Inc..","evidence_excerpt":"On October 24, 2024, Michael Torok notified Carisma Therapeutics Inc. (the “Company”) of his decision to resign from the Company’s board of directors (the “Board”), effective October 31, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1485003/000110465924112629/0001104659-24-112629-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}